Background/Aims: Stem cell transplantation has emerged as a promising therapeutic strategy, but the exact mechanisms by which stem cells exposed to hypoxic conditions increase the survival rate and rescue ischemic injury at the graft site are not well known. In this study, we aimed to determine if c-Met-activated mesenchymal stem cells (MSCs) preand whether c-Met interacts with cellular prion protein (PrP C ) present in the ischemic tissue. Methods: Western blot analysis was performed to determine the expression levels of PrP C , C-caspase-3, and C-PARP-1, as well as the phosphorylation of Akt, p38, JNK, and BAX. A coimmunoprecipitation assay was performed to show that PrP C binds with c-Met in vitro. An adhesion assay was performed to explore the alterations in MSCs attached to myoblasts (in vitro), and an invasion assay was performed to determine the effect on MSC invasion capacity upon interaction with myoblast-induced c-Met and PrP C positive arterioles in in vivo staining. The level of apoptosis in the tissue of each group was assessed by quantifying the number of C-caspase-3-positive cells. Finally, laser Doppler technology was utilized to detect the enhanced angiogenic effects in vivo. Results: We showed that hypoxic conditions increased PrP C levels in vivo (hindlimb ischemic tissue) and in vitro (myoblasts) and increased c-Met levels in MSCs. To identify the relationship between c-Met from MSCs and PrP C from myoblasts, we used a co-culturing system with myoblasts and MSCs pre-exposed to hypoxia. Hypoxia increased the phosphorylation of mitogen-activated protein kinases. Transplantation of hypoxia-pre-exposed MSCs to the ischemic site increased anti-apoptosis and enhanced the survival and proliferation of transplanted MSCs in a murine hindlimb model, resulting Sang Hun Lee, Ph.D.
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Introduction
Human mesenchymal stem cells (MSCs) are multipotent adult stem cells that are commonly incorporated into various therapeutic interventions for degenerative diseases, such as anemia, arterial disease, and ischemic strokes [1] [2] [3] [4] [5] . Their therapeutic potential, however, is severely limited by hypoxic and oxidative stresses endemic to the ischemic environment, which preclude their ability to facilitate vasculogenesis and tissue repair [6] . made using such methods are limited by unforeseen consequences [7] . An alternative method involving the pre-exposure of MSCs to hypoxic conditions (1-3% O 2 ) has been shown to improve the therapeutic potential of MSCs in a murine hindlimb ischemia model, particularly by building up their resistance to ischemic conditions [8] . In addition, it has been demonstrated that ischemic conditions increase the levels of cellular prion proteins (PrP C ) [9] . Bound to the plasma membrane by a glycosylphosphatidylinositol anchor, PrP C is dispersed throughout the human body, particularly in the central nervous system, heart, skeletal muscle, intestinal tissue, uterus, and testis [10] . PrP C , which is encoded by the PRNP caused by ischemia, which leads to reactive oxygen species production, DNA damage, and cell apoptosis, can be alleviated by the detoxifying effects of PrP C [13] , possibly via the action of its ligand, STI-1, which promotes the migration and proliferation of bone marrow-derived cells to the ischemic brain [14] . In short, conditions of hypoxia and oxidative damage that follow ischemia result in the accumulation of PrP C [11] , in addition to improving the therapeutic PrP C and multipotent stem cells in response to ischemia have not been studied. c-Met is a tyrosine kinase transmembrane receptor that binds its ligand, hepatocyte growth factor (HGF), to activate a variety of signaling pathways, including the mitogenactivated protein kinase (MAPK), phosphoinositide-3-kinase/Akt, and SRC pathways [15] . Its ability to activate pathways related to proliferation, motility, migration, and invasion makes it a prime subject for targeted therapeutic intervention. Although c-Met is typically expressed in epithelial cells, studies have suggested that its functional form is also expressed in MSCs, indicating that it may play a role in mobilizing these stem cells and helping them in the wound healing process [16] . Previous studies have demonstrated that c-Met enhances the ability of MSCs to migrate to the sites of injury after acute liver failure [17] . The same phenomenon has been observed in vascular ulcers; the activity of HGF and c-Met in arterial MSCs supplements cell migration, angiogenesis, and vasculogenesis [18] . Moreover, pretreatment of MSCs with HGF enhances their ability to respond to ischemia by promoting cell migration and cytokine secretion, which augment regeneration and wound healing [19] . Although the ability of HGF/c-Met to facilitate mobility and support the repair functions of MSCs has been reported, the interaction between c-Met and the prion proteins that are upregulated during ischemic hypoxia has not yet been well studied. 
Materials and Methods

MSC culture
Primary myoblast culture
Myoblasts were isolated by dissecting the hind limb muscle of a mouse under sterile conditions. The tissue was placed in phosphate-buffered saline (PBS), and the muscle was minced into a coarse slurry using razor blades and sterile surgical scissors in a culture plate. The muscle slurry was transferred to a sterile slurry was then passed through an 80 µm nylon mesh (Millipore Inc., Billerica, MA, USA) to remove the large in growth medium; and the suspension was plated in culture plates. Myoblasts were cultured in Dulbecco's
Hypoxia precondition
MSCs or myoblasts were incubated in a modular incubator chamber (IB Science, Daejeon, Korea) maintaining a hypoxic gas mixture (2% O 2 , 5% CO 2 , and balanced N 2
Western blot analysis All cell homogenates (total protein, 20 µg) were separated using 8-12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis. Proteins were transferred onto nitrocellulose membranes. After the membranes were washed with a solution containing Tris-HCl (10 mM, pH 7.6), NaCl (150 mM), and Tween 20 (0.05%), the membranes were pre-incubated with skimmed milk (5%) for 1 h at room temperature, USA), PrP C (Santa Cruz Biotechnology), c-Met (Santa Cruz Biotechnology), phospho-Akt (p-Akt; Thermo
Cruz Biotechnology), cleaved caspase-3 (C-caspase-3; Santa Cruz Biotechnology), cleaved poly(ADP ribose) (Santa Cruz Biotechnology). The membranes were washed thrice, and primary antibodies were detected using horseradish peroxidase-conjugated goat anti-rabbit/anti-mouse IgG secondary antibodies (Santa
Co-immunoprecipitation
The co-immunoprecipitation of c-Met in MSCs and PrP C in myoblasts was analyzed. After direct coMSCs and myoblasts via sonication in a co-immunoprecipitation buffer. The c-Met-PrP C complexes were C was detected using anti-PrP C antibodies (Santa Cruz Biotechnology) by western blot analysis. 
Invasion assay
Merck Millipore). To establish an environment similar to that in the muscle tissue in vitro 4 ) were seeded into the chambers of pretreated under hypoxic culture conditions (2% O 2 , 5% CO 2 , and balanced N 2 ) for 24 h, or were subjected to increased expression of PrP C by PRNP in PBS and stained with 2% crystal violet in 2% ethanol; non-invasive cells were eliminated using a cotton
Adhesion assay 4 h, unattached cells were removed using PBS. Myoblasts and MSCs were dissociated into single cells using trypsin, and the amount of MSCs was measured using FACS analysis.
Cell survival assay
MSCs (3000 cells/well) were seeded in a 96-well plate and incubated under normoxic or hypoxic yl)-2, 5-diphenyltetrazolium bromide (MTT) assay, which is based on the conversion of the tetrazolium salt 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2-tetrazolium to formazan by mitochondrial NAD(P)H-dependent oxidoreductase enzymes. The absorbance of formazan was measured at 575 nm using a microplate reader (Tecan, Männedorf, Switzerland).
Wound-healing migration assay
well. The cell layer was scratched using a 2-mm-wide tip to make a line-shaped wound. 
Statistical analysis
analysis of variance (ANOVA). For comparing the means of more than three groups, the Bonferroni-Dunn
Results
C levels in vivo and in vitro To identify the alterations in PrP
C levels under ischemic and hypoxic conditions using in vivo and in vitro models, we used a hindlimb ischemia mouse model and primary-cultured C and PrP C C levels increased in a time-dependent manner (Fig. 1a) . Under ischemic conditions, the number of PrP C -positive cells in the hindlimb also increased (Fig. 1b) . Moreover, exposure C levels in the primary-cultured myoblasts (Fig. 1c) ; however, this increase was inhibited by pretreatment increases PrP C in vivo and in vitro.
Interaction of c-Met and PrP
C increased the mobilization of MSCs under hypoxic conditions To explore the association between PrP C and c-Met in the regulation of MSC mobilization, to hypoxic conditions resulted in a time-dependent increase in c-Met levels (Fig. 2a) . Meanwhile, maximal levels of c-Met were observed 6-12 h after hypoxic exposure (Fig. 2a) . C of myoblasts binds to the c-Met of MSCs. Direct co-cultivation of myoblasts and MSCs showed an increase in the interaction between c-Met and PrP C under hypoxic conditions in contrast to that under normoxic conditions (Fig. 2b) . To identify the potential role of the PrP C of myoblasts in regulating MSC mobilization, we performed a small-scale screening of myoblasts transiently transfected with PRNP and the empty vector, followed by western blot analysis (Fig. 2c) , we performed invasion assays by co-culturing MSCs with myoblasts under hypoxic conditions. As shown in Fig. 2d and e, exposure of myoblasts to hypoxia and indirect co-culture with MSCs promoted MSC migration. Moreover, the overexpression of PrP C in myoblasts and indirect co-culture with MSCs was similar to that after hypoxia exposure ( Fig.  2d and e) , and was inhibited by c-Met neutralization (Fig. 2d and e) . To explore the alteration in the attachment of MSCs to myoblasts, we performed the adhesion assay. The exposure of myoblasts to hypoxia promoted the adhesion of MSCs similarly in both PrP C -overexpressing and hypoxia-exposed myoblasts (Fig. 2f and g ), which was inhibited by c-Met neutralization ( Fig. 2f and g ). These results suggest that increased PrP C levels in myoblasts exposed to hypoxic conditions increase the mobility of MSCs by interacting with the c-Met of MSCs. 
Hypoxia-induced c-Met regulates the proliferation and migration of MSCs via Akt/MAPKs
A previous study demonstrated that hypoxia enhances cell proliferation through the Aktevaluated by western blot analysis in MSCs. Hypoxia increased the phosphorylation of Akt, addition, hypoxia-exposed MSCs have been shown to promote proliferation and migration ( Fig. 3e and f) . However, the pretreatment of MSCs with c-Met-neutralizing antibodies inhibited the proliferation and migration of MSCs promoted by hypoxic conditions (Fig. 3e  and f) . Taken together, these results suggest that hypoxia enhances the proliferation and migration potential of MSCs through c-Met-mediated activation of the Akt/MAPK pathway.
Hypoxia-mediated increase in c-Met levels enhanced MSC survival at the ischemic site
To examine whether the transplanted hypoxia-pre-exposed MSCs increased survival at the ischemic site via c-Met activation, the ischemic tissues were harvested at postoperative exposed MSCs compared with other groups (Fig. 4a) ; however, this effect was inhibited by hypoxia-pre-exposed MSCs compared with other groups (Fig. 4b-d ). In addition, the level Fig. 3 .
normoxic MSCs, MSCs pre-exposed to hypoxic conditions for 12 h, and hypoxia-pre-exposed MSCs pretreat-## wound-healing migration assay of normoxic MSCs, MSCs pre-exposed to hypoxia for 12 h, and hypoxia-pre-## pre-exposed to hypoxia. of apoptosis in the tissues of each group was then assessed by quantifying the number of C-caspase-3-positive cells ( Fig. 4e and f) . The results indicated that MSCs pre-exposed to hypoxia inhibit apoptosis at the ischemic site, but neutralization with c-Met does not prevent apoptosis in MSCs.
c-Met-activated MSCs pre-exposed to hypoxia enhance neovascularization in the ischemic tissues
which is indicated by increased angiogenic cytokine expression at the ischemic site via c-Met with hypoxia-pre-exposed MSCs (Fig. 5a) . However, c-Met-neutralized MSCs pre-exposed to transplanted with hypoxia-pre-exposed MSCs than in those transplanted with PBS or MSCs alone ( Fig. 5b-e) . However, pretreatment with the c-Met-neutralizing antibody inhibited the hypoxia-induced capillary and arteriole formation (Fig. 5b-e) . These results suggested that MSCs pre-exposed to hypoxia improve neovascularization via c-Met activation in ischemic tissues in vivo. 
Hypoxia-mediated c-Met activation in MSCs improved functional recovery in a murine hindlimb ischemia model
To determine whether c-Met-activated MSCs pre-exposed to hypoxia exhibit enhanced vascular repair in vivo, blood perfusion and tissue repair were investigated following the transplantation of PBS, normoxic MSCs, hypoxia-pre-exposed MSCs, and hypoxia-pre-exposed MSCs pretreated with the c-Met-neutralizing antibody into the ischemic thigh muscles of murine hindlimbs. Blood perfusion was assessed by laser Doppler on postoperative days 0 to ratios than those of other groups (Fig. 6a and b) ; however, pretreatment with the c-Metneutralizing antibody inhibited this effect (Fig. 6a and b) . In addition, the therapeutic effect of MSC transplantation in hindlimb ischemic sites was evaluated by determining toe loss Fig. 6c and d) , the transplantation of MSCs pretreated with c-Met did not inhibit the necrosis of the mouse hindlimb ( Fig. 6c and d) . These data indicate that transplantation of c-Met-activated MSCs pre-exposed to hypoxia results in enhanced Discussion activated MSCs interact with PrP C under hypoxic conditions to promote ischemic rescue in both in vivo and in vitro models. MSCs have been used in many clinical treatments, especially in various ischemic conditions [24] [25] [26] . Their potential, however, is known to be limited by numerous factors that restrict their proliferative potential [27] [28] [29] . Previous studies have suggested that PrP C plays an integral role in MSC proliferation, highlighting its applicability in . Thus, our study aimed to elucidate the precise mechanism of PrP C -induced MSC proliferation in both in vivo and in vitro models. Interestingly, our results showed that pre-exposure to hypoxia upregulates PrP C expression in the murine hindlimb ischemic tissue and myoblasts. This result suggests that PrP C generation is independent of MSCs, and it is generated beforehand within the prehypoxia-conditioned tissue, indicating that there has to be a mediator in MSCs that interacts with the generated PrP C , which ultimately induces MSC expansion in ischemic conditions. clinical applications [16, 17] . Moreover, c-Met has been deemed to be an important signaling molecule in the clinical application of MSCs in ischemia [19] . Our present results showed that hypoxia induces an increase in c-Met expression in MSCs cultured in hypoxic conditions in vitro. In addition, invasion assays of co-cultures of myoblasts and hypoxia-pre-exposed MSCs revealed that c-Met and its interaction with overexpressed PrP C enhance MSC invasion and adhesion after pretreatment. These increased invasive and adhesive capabilities of transplanted MSCs are suppressed when c-Met is inhibited, suggesting the critical role of c-Met in PrP C -induced MSC proliferation. In addition, our study showed that c-Met enhances MSC proliferation by inducing Akt/MAPK expression, which is in accordance with a previous Akt-MAPK cell survival pathway and regulates the proliferation and migration of MSCs in ischemic damage.
Next, to elucidate the precise pathway by which hypoxia exposure and increased c-Met known to be responsible for suppressing programmed cell death or apoptosis [32, 33] . Thus, our results demonstrated that exposure of MSCs to hypoxia had potential therapeutic effects. In addition, the levels of widely known proteins involved in cellular apoptosis, including with hypoxia-pre-exposed MSCs, further supporting our hypothesis. Most importantly, the importance of c-Met in ischemic rescue. Although numerous in vitro replace numerous body tissues, such as the smooth muscle, endothelium, and myocardial muscle, the primary limitation remains in its translational ability in in vivo models. Previous studies have suggested that the predominant mechanism of MSC-mediated in vivo tissue levels of which have been found to increase after exposure of MSCs to hypoxia [35] [36] [37] . More angiogenesis, and functional recovery [38, 39] . Thus, in our study, we investigated the essentiality of c-Met in MSC clinical application in ischemic disease in vivo. Our results from the laser Doppler blood perfusion experiment suggested that mice that received hypoxiapre-exposed MSCs experienced enhanced angiogenesis, compared to those that received control treatment or normoxic MSCs. Hypoxia-pre-exposed MSCs pretreated with the c-Metneutralizing antibody reduced the angiogenic effects of its counterpart model, suggesting the critical role of c-Met in ischemic rescue. Besides cellular growth and angiogenesis, we also observed the macroscopic and functional recoveries in the in vivo mouse models of hypoxia-pre-exposed MSCs; however, these effects were inhibited by pretreatment with c-Met. In conclusion, using both in vitro and in vivo models, we present a novel discovery that c-Met plays an important role in hypoxia and the PrP C ischemia rescue pathway. Our the commonly known proliferative agent PrP C to enhance the therapeutic application of 
